Lack of Association Between the Serotonin Transporter and Serotonin 1A Receptor: an in Vivo PET Imaging Study in Healthy Adults
Overview
Psychiatry
Radiology
Authors
Affiliations
The serotonin neurotransmitter system is modulated in part by the uptake of synaptically released serotonin (5-HT) by the serotonin transporter (5-HTT), and by specific serotonin autoreceptors such as the somatodendritic 5-HT1A receptor, which can limit serotonin neuron depolarization. However, little is known about how 5-HTT and 5-HT1A are related in vivo. To study this question, we reanalyzed positron emission tomography (PET) data obtained earlier in 40 healthy participants (21 females) using [(11)C]WAY-100635 for quantification of 5-HT1A binding and [(11)C](+)-McN-5652 for quantification of 5-HTT binding. We hypothesized negative correlations between 5-HT1A binding in the raphe nuclei (RN) and 5-HTT binding in RN terminal field regions. Controlling for sex, no significant correlations were found (all p>0.05). Similarly, an exploratory analysis correlating whole-brain voxel-wise 5-HTT binding with 5-HT1A binding in RN identified no significant clusters meeting our a priori statistical threshold. The lack of correlation between 5-HT1A and 5-HTT binding observed in the current study may be due to the different temporal responsiveness of regulatory processes controlling the somatodendritic 5-HT1A receptor and 5-HTT in response to changing availability of intrasynaptic serotonin.
Svensson J, Tiger M, Plaven-Sigray P, Halldin C, Schain M, Lundberg J Neuropsychopharmacology. 2022; 47(10):1863-1868.
PMID: 35821068 PMC: 9372190. DOI: 10.1038/s41386-022-01369-3.
Saylor R, Hersey M, West A, Buchanan A, Berger S, Nijhout H Front Neurosci. 2019; 13:362.
PMID: 31110471 PMC: 6499219. DOI: 10.3389/fnins.2019.00362.
Molecular connectivity disruptions in males with major depressive disorder.
Pillai R, Zhang M, Yang J, Mann J, Oquendo M, Parsey R J Cereb Blood Flow Metab. 2018; 39(8):1623-1634.
PMID: 29519187 PMC: 6681531. DOI: 10.1177/0271678X18764053.
Ananth M, DeLorenzo C, Yang J, Mann J, Parsey R J Nucl Med. 2017; 59(4):665-670.
PMID: 28935838 PMC: 5932749. DOI: 10.2967/jnumed.117.189654.
Iscan Z, Rakesh G, Rossano S, Yang J, Zhang M, Miller J Eur Neuropsychopharmacol. 2017; 27(10):1011-1021.
PMID: 28811068 PMC: 5623123. DOI: 10.1016/j.euroneuro.2017.07.009.